| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cca165d58f27686da488f4d61fcde5fb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-3478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0116
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0147 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0144
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-00234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0125 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-01 |
| filingDate |
2019-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_947d237f6db867cab70103b702fb02f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ca9a74d7b0d96f51af43441ec5b3696
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6299dcd78c1b3ce2eb63a0db67e2f17b |
| publicationDate |
2021-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11129603-B2 |
| titleOfInvention |
Guidewireless transseptal delivery system for therapeutic devices of the aortic valve |
| abstract |
A system and method used to deliver an aortic valve therapeutic device to an aortic valve site includes a cable percutaneously introduced a cable into a vasculature of a patient and positioned to run from a femoral vein, through the heart via a transeptal puncture, and to a femoral artery. The therapeutic device is passed over an end of the cable at the venous side and is secured to the cable. The therapeutic device is pushed in a distal direction while the second end of the cable is pulled in the proximal direction to advance the therapeutic device to the mitral valve site. A left ventricle redirector aids in orienting the therapeutic device and preventing migration of the cable towards delicate mitral valve structures and chordae tendoneae during advancement of the therapeutic device. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648395-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11559687-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11607176-B2 |
| priorityDate |
2017-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |